Dr. David Morris, MD
NPI: 1194841452
Total Payments
$946,880
2024 Payments
$115,575
Companies
82
Transactions
2,007
Medicare Patients
15,511
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$637,751 (67.4%)
Consulting$166,741 (17.6%)
Travel$94,274 (10.0%)
Food & Beverage$47,101 (5.0%)
Education$546.20 (0.1%)
Research$466.33 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $569,353 | 295 | 60.1% |
| Consulting Fee | $166,741 | 71 | 17.6% |
| Travel and Lodging | $94,274 | 255 | 10.0% |
| Honoraria | $63,998 | 44 | 6.8% |
| Food and Beverage | $47,101 | 1,320 | 5.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,400 | 1 | 0.5% |
| Education | $546.20 | 11 | 0.1% |
| Unspecified | $466.33 | 10 | 0.0% |
Payments by Type
General
$946,413
1,997 transactions
Research
$466.33
2 transactions
Ownership
$0
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $212,453 | 209 | $0 (2024) |
| Astellas Pharma US Inc | $162,835 | 296 | $0 (2024) |
| Janssen Biotech, Inc. | $140,952 | 280 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $101,342 | 121 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $43,859 | 121 | $0 (2024) |
| SN Holdings, LLC | $39,353 | 63 | $0 (2024) |
| PFIZER INC. | $33,431 | 90 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $30,189 | 26 | $0 (2024) |
| UroGPO LLC | $28,325 | 46 | $0 (2020) |
| Myovant Sciences Inc. | $21,059 | 57 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115,575 | 288 | Astellas Pharma US Inc ($32,249) |
| 2023 | $179,352 | 312 | Bayer Healthcare Pharmaceuticals Inc. ($39,568) |
| 2022 | $145,165 | 305 | Bayer HealthCare Pharmaceuticals Inc. ($65,294) |
| 2021 | $100,436 | 278 | AstraZeneca Pharmaceuticals LP ($25,602) |
| 2020 | $113,261 | 183 | Bayer HealthCare Pharmaceuticals Inc. ($31,825) |
| 2019 | $126,656 | 260 | Bayer HealthCare Pharmaceuticals Inc. ($46,634) |
| 2018 | $78,051 | 186 | Janssen Scientific Affairs, LLC ($23,789) |
| 2017 | $88,383 | 195 | Dendreon Pharmaceuticals LLC ($33,856) |
All Payment Transactions
2,007 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/20/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: Diagnostic Imaging | ||||||
| 12/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/18/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Vessel Sealing | ||||||
| 12/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,275.00 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | PFIZER INC. | TALZENNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,725.00 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $132.74 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Consulting Fee | In-kind items and services | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $123.23 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: HORMONE THERAPY | ||||||
| 12/03/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/22/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/21/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: UROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT) | Astellas Pharma Global Development | $466.33 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,495 | 10,687 | $1.1M | $404,726 |
| 2022 | 41 | 3,694 | 12,420 | $1.1M | $379,979 |
| 2021 | 41 | 4,073 | 16,846 | $1.3M | $476,107 |
| 2020 | 41 | 4,249 | 20,959 | $1.3M | $507,289 |
Total Patients
15,511
Total Services
60,912
Medicare Billing
$1.8M
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 19 | 1,260 | $148,680 | $83,715 | 56.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 70 | 573 | $315,150 | $77,421 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 583 | 910 | $227,500 | $74,082 | 32.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 3,840 | $115,200 | $69,875 | 60.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 419 | 519 | $88,230 | $29,280 | 33.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 354 | 595 | $42,840 | $10,674 | 24.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 180 | 374 | $27,302 | $9,413 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $33,704 | $9,007 | 26.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 42 | 46 | $24,196 | $7,855 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 380 | 679 | $6,790 | $5,671 | 83.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 15 | $15,315 | $4,528 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 37 | $16,132 | $3,587 | 22.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 87 | 133 | $8,246 | $3,064 | 37.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 13 | 13 | $6,292 | $2,053 | 32.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 15 | 44 | $6,952 | $1,756 | 25.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 12 | 14 | $18,656 | $1,638 | 8.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 16 | $4,768 | $1,591 | 33.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 370 | 503 | $5,533 | $1,553 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,016 | $1,316 | 32.8% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 12 | 12 | $3,024 | $1,237 | 40.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 410 | 532 | $3,724 | $1,147 | 30.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 45 | 83 | $1,660 | $859.05 | 51.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 61 | 72 | $3,168 | $569.52 | 18.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 52 | $2,028 | $509.60 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,313 | $497.28 | 37.9% |
About Dr. David Morris, MD
Dr. David Morris, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Hendersonville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194841452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Morris, MD has received a total of $946,880 in payments from pharmaceutical and medical device companies, with $115,575 received in 2024. These payments were reported across 2,007 transactions from 82 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($569,353).
As a Medicare-enrolled provider, Morris has provided services to 15,511 Medicare beneficiaries, totaling 60,912 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Urology
- Location Hendersonville, TN
- Active Since 03/21/2007
- Last Updated 08/07/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1194841452
Products in Payments
- Nubeqa (Drug) $149,298
- ERLEADA (Drug) $95,440
- LYNPARZA (Drug) $95,403
- XTANDI (Drug) $80,862
- Xtandi (Drug) $71,523
- Erleada (Drug) $65,867
- PROVENGE (Drug) $49,504
- Xofigo (Drug) $47,732
- ORGOVYX (Drug) $40,186
- ELIGARD (Drug) $15,363
- Non-Covered (Drug) $13,349
- Rubraca (Drug) $13,083
- TALZENNA (Drug) $12,469
- KEYTRUDA (Biological) $11,261
- POSLUMA (Drug) $10,220
- PYLARIFY (Drug) $6,373
- Enzalutamide (Drug) $5,762
- RUBRACA (Drug) $5,427
- Prolia (Biological) $4,403
- ENZALUTAMIDE (Drug) $4,351
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Hendersonville
Dr. Andrew Wicke, D.m.d, D.M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,102
Student in an Organized Health Care Education/Training Program $5,102
Nina Harkhani, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $5,004
Student in an Organized Health Care Education/Training Program $5,004
Lilly Zhu
Student in an Organized Health Care Education/Training Program — Payments: $3,774
Student in an Organized Health Care Education/Training Program $3,774
Jessica Brennan, Pa-C, PA-C
Student in an Organized Health Care Education/Training Program — Payments: $2,109
Student in an Organized Health Care Education/Training Program $2,109
Christopher Hall
Student in an Organized Health Care Education/Training Program — Payments: $2,099
Student in an Organized Health Care Education/Training Program $2,099
Dustin Alderson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,103
Student in an Organized Health Care Education/Training Program $1,103